CSPC Pharmaceutical Group Statistics
Total Valuation
CSPCY has a market cap or net worth of 12.90 billion. The enterprise value is 11.94 billion.
Market Cap | 12.90B |
Enterprise Value | 11.94B |
Important Dates
The last earnings date was Friday, May 23, 2025.
Earnings Date | May 23, 2025 |
Ex-Dividend Date | Jun 5, 2025 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -1.85% |
Shares Change (QoQ) | -1.02% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 7.82B |
Valuation Ratios
The trailing PE ratio is 22.33 and the forward PE ratio is 17.87.
PE Ratio | 22.33 |
Forward PE | 17.87 |
PS Ratio | 3.46 |
PB Ratio | 2.77 |
P/TBV Ratio | 3.17 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 20.67 |
EV / Sales | 3.23 |
EV / EBITDA | 14.36 |
EV / EBIT | 18.23 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.01 |
Debt / EBITDA | 0.08 |
Debt / FCF | n/a |
Interest Coverage | 109.38 |
Financial Efficiency
Return on equity (ROE) is 12.21% and return on invested capital (ROIC) is 8.64%.
Return on Equity (ROE) | 12.21% |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | 8.64% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 174,135 |
Profits Per Employee | 27,002 |
Employee Count | 21,400 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +18.63% in the last 52 weeks. The beta is 0.78, so CSPCY's price volatility has been lower than the market average.
Beta (5Y) | 0.78 |
52-Week Price Change | +18.63% |
50-Day Moving Average | 3.01 |
200-Day Moving Average | 2.68 |
Relative Strength Index (RSI) | 69.08 |
Average Volume (20 Days) | 1,935 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CSPCY had revenue of 3.73 billion and earned 577.85 million in profits. Earnings per share was 0.05.
Revenue | 3.73B |
Gross Profit | 2.55B |
Operating Income | 667.88M |
Pretax Income | 732.66M |
Net Income | 577.85M |
EBITDA | 823.15M |
EBIT | 667.88M |
Earnings Per Share (EPS) | 0.05 |
Balance Sheet
The company has 1.26 billion in cash and 69.91 million in debt, giving a net cash position of 1.19 billion.
Cash & Cash Equivalents | 1.26B |
Total Debt | 69.91M |
Net Cash | 1.19B |
Net Cash Per Share | n/a |
Equity (Book Value) | 4.67B |
Book Value Per Share | 0.39 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 68.45%, with operating and profit margins of 17.92% and 15.51%.
Gross Margin | 68.45% |
Operating Margin | 17.92% |
Pretax Margin | 19.66% |
Profit Margin | 15.51% |
EBITDA Margin | 22.09% |
EBIT Margin | 17.92% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.11, which amounts to a dividend yield of 2.58%.
Dividend Per Share | 0.11 |
Dividend Yield | 2.58% |
Dividend Growth (YoY) | -6.63% |
Years of Dividend Growth | 6 |
Payout Ratio | n/a |
Buyback Yield | 1.85% |
Shareholder Yield | 4.43% |
Earnings Yield | 4.48% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on November 16, 2020. It was a forward split with a ratio of 1.6.
Last Split Date | Nov 16, 2020 |
Split Type | Forward |
Split Ratio | 1.6 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |